Ignite Creation Date:
2025-12-24 @ 4:53 PM
Ignite Modification Date:
2026-02-26 @ 12:36 AM
Study NCT ID:
NCT01074450
Status:
COMPLETED
Last Update Posted:
2010-04-30
First Post:
2010-02-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
R04-1202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None